Table 1.
Baseline demographic characteristics of analyzed groups.
| Parameter (mean ± SEM) |
Athletes N = 25 |
Control N = 54 |
p |
|---|---|---|---|
| Age [years] | 23,52 ± 0,37 | 24,58 ± 0,55 | 0,07 |
| HR [bpm] | 69,00 ± 2,43 | 72,08 ± 1,94 | 0,21 |
| SBP [mmHg] | 122,91 ± 1,94 | 126,78 ± 2,57 | 0,07 |
| DBP [mmHg] | 81,45 ± 1,84 | 81,21 ± 1,89 | 1,00 |
| MAP [mmHg] | 95,27 ± 1,65 | 96,12 ± 1,96 | 0,55 |
| PP [mmHg] | 41,45 ± 1,89 | 46,40 ± 2,03 | 0,04 |
| BMI [kg/m2] | 25,82 ± 0,58 | 26,41 ± 0,66 | 0,57 |
| WHR [1] | 0,95 ± 0,0 | 0,938 ± 0,01 | 0,29 |
| TCh [mg/dl] | 161,04 ± 5,93 | 182,25 ± 6,95 | 0,01 |
| HDL [mg/dl] | 55,7 ± 2,83 | 48,73 ± 1,58 | 0,03 |
| LDL [mg/dl] | 82,28 ± 5,25 | 105,2 ± 5,70 | 0,006 |
| TG [mg/dl] | 112,36 ± 14,54 | 147,85 ± 12,46 | 0,07 |
| hsCRP [mg/l] | 3,52 ± 0,23 | 2,40 ± 0,37 | 0,003 |
| Glucose [mg/dl] | 84,66 ± 2,17 | 84,53 ± 1,81 | 0,68 |
| Creatinine [mg/dl] | 0,96 ± 0,02 | 0,96 ± 0,02 | 0,70 |
| eGFR [ml/(min × 1,73 m2)] | 147,48 ± 4,98 | 130,44 ± 8,19 | 0,07 |
| Uric acid [mg/dl] | 6,15 ± 0,26 | 6,18 ± 0,23 | 0,98 |
| K+ [mmol/l] | 3,98 ± 0,05 | 5,03 ± 0,05 | 0,10 |
| Na+ [mmol/l] | 142,65 ± 0,22 | 141,42 ± 0,32 | 0,02 |
| Urea [mg/dl] | 36,62 ± 1,41 | 31,4 ± 1,35 | 0,003 |
| C-R PWV [m/s] | 9,61 ± 0,36 | 10,69 ± 0,34 | 0,04 |
| C-F PWV [m/s] | 9,51 ± 0,24 | 9,90 ± 0,32 | 0,67 |
| C-D PWV [m/s] | 8,15 ± 0,19 | 8,91 ± 0,24 | 0,01 |
SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean blood pressure; PP: pulse pressure; BMI: body mass index; WHR: waist-hips ratio; TCh: total cholesterol; HDL: high-density lipoproteins; LDL: low-density lipoproteins; TG: triglycerides; eGFR: estimated glomerular filtration rate; hsCRP: high-sensitivity C-reactive protein; C-R PWV: carotid-radial pulse wave velocity, C-F PWV: carotid-femoral pulse wave velocity; C-D PWV: carotid-dorsal pedis pulse wave velocity.